PrEP through pharmacies for young women in Tanzania
Part of Infections clinical trials.
This study looks at whether young women can get PrEP, a daily pill that prevents HIV, from local pharmacies instead of clinics. It aims to make it easier for adolescent girls and young women to start and continue PrEP in selected areas of Tanzania.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 24 years old.
- You live in one of the study areas in Shinyanga, Geita, or Kagera regions and don't plan to move soon.
- You are interested in starting PrEP (the HIV prevention pill).
- You have access to a mobile phone, either your own or someone else's.
- You are not currently taking PrEP (you haven't refilled a PrEP prescription in the last 28 days).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers different forms of HIV prevention medicine (PrEP) to young women ages 18–30 who are visiting clinics for reproductive health services like family planning or postnatal care. It aims to see which delivery method works best for you.
This study tests whether pharmacies can offer HIV prevention medications (PrEP/PEP) with remote nurse support. It aims to make HIV prevention easier to access in the community.
This study aims to expand access to PrEP (a daily pill that prevents HIV) for pregnant and postpartum women visiting maternal and child health clinics in Kenya. It also includes health care workers who provide PrEP services.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
This study tests a support program to help young women stick with their HIV prevention medicine (PrEP). It aims to see if extra support helps them keep taking it regularly.
This study tests a program to help adolescent girls and young women at high risk of HIV take PrEP consistently. It aims to improve access and adherence to PrEP, a daily pill that prevents HIV.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.